Stem Cell Boosting Treatments Can Reduce The Damaging Impact Of New Myeloma Drug On Patient Stem Cells
    By Jennifer Wong | February 4th 2013 04:13 PM | 5 comments | Print | E-mail | Track Comments


    Did you mean to say "melanoma" in the last sentence of paragraph 2?

    You're right...Thanks for pointing that out.
    What is the new drug(s) here, all the agents mentioned in the article are at least 5 years old, and thalidomide is over 50 years old.

    That's true- the drugs mentioned here can't really be discovered today- given this paper is based on a 10-year retrospective study. I suppose in the clinical setting; particularly in  a retrospective study- "new" is a relative concept.
    Great article, Jennifer. I think I've come across this before, though. I had a textbook in college written by Dr. Rongxiang in China. I remember seeing pictures. This works because it suffocates the deadly cells right by boosting the amount of healthy cells?